Cargando…
Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response
Introduction Pharmacogenetic testing is proposed to minimize adverse effects when considered in combination with pharmacological knowledge of the drug. As yet, limited studies in clinical settings have investigated the predictive value of pharmacokinetic (pk) gene variation on therapeutic drug level...
Autores principales: | Scherf-Clavel, Maike, Weber, Heike, Wurst, Catherina, Stonawski, Saskia, Hommers, Leif, Unterecker, Stefan, Wolf, Christiane, Domschke, Katharina, Rost, Nicolas, Brückl, Tanja, Lucae, Susanne, Uhr, Manfred, Binder, Elisabeth B., Menke, Andreas, Deckert, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458342/ https://www.ncbi.nlm.nih.gov/pubmed/35839823 http://dx.doi.org/10.1055/a-1872-0613 |
Ejemplares similares
-
Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age
por: Hommers, Leif, et al.
Publicado: (2021) -
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study
por: Scherf-Clavel, Maike, et al.
Publicado: (2023) -
FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression
por: Ising, Marcus, et al.
Publicado: (2019) -
Possible Associations of NTRK2 Polymorphisms with Antidepressant Treatment Outcome: Findings from an Extended Tag SNP Approach
por: Hennings, Johannes M., et al.
Publicado: (2013) -
Inhibition of acid sphingomyelinase increases regulatory T cells in humans
por: Wiese, Teresa, et al.
Publicado: (2021)